Milestone Pharmaceuticals (NASDAQ:MIST) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Milestone Pharmaceuticals (MIST) operate in?

Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.

Open	$1.85
Close	$1.85
Volume / Avg.	129.52K / 330.30K
Day Range	$1.81 - $1.86
52 Wk Range	1.12 - 2.93
Market Cap	$99.17M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.97%
Days to Cover	1.18

Recent News

Milestone Pharmaceuticals Upgraded to Buy: Here's What You Should Know

Milestone Pharmaceuticals (NASDAQ: MIST) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

Zacks

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Avi Kapoor

Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.85
Close	$1.85
Volume / Avg.	129.52K / 330.30K
Day Range	$1.81 - $1.86
52 Wk Range	1.12 - 2.93
Market Cap	$99.17M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.97%
Days to Cover	1.18

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Milestone Pharmaceuticals (MIST) stock?

You can purchase shares of Milestone Pharmaceuticals (NASDAQ:MIST) through any online brokerage.

View our list of the best stock brokerages

Who are Milestone Pharmaceuticals (MIST) competitors?

Other companies in Milestone Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Iterum Therapeutics (NASDAQ:ITRM), Bioage Labs (NASDAQ:BIOA), Telomir Pharmaceuticals (NASDAQ:TELO) and Reviva Pharmaceuticals (NASDAQ:RVPH).

What is the forecast, or price target, for Milestone Pharmaceuticals (MIST) stock?

Milestone Pharmaceuticals has a consensus price target of $10.83.

What is the current price for Milestone Pharmaceuticals (MIST)?

The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $1.8597 last updated December 24, 2024 at 3:47 PM EST.

Does Milestone Pharmaceuticals (MIST) pay a dividend?

There are no upcoming dividends for Milestone Pharmaceuticals.

When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?

Milestone Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 20, 2025.

Is Milestone Pharmaceuticals (MIST) going to split?

There is no upcoming split for Milestone Pharmaceuticals.

What sector and industry does Milestone Pharmaceuticals (MIST) operate in?

Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Milestone Pharmaceuticals

Milestone Pharmaceuticals (MIST) Forecast